Showing results (91-100 of 104) with videos related to

Sort By:
Pageof 11
Clinical Transplantation|May 4, 2023
Impact of newly diagnosed prostate cancer at time of evaluation for renal transplantationFlorence Poinard, Thomas Bessede, Benoit Barrou, et al.
Urologic Oncology|January 18, 2020
Morbidity, perioperative outcomes and complications of robot-assisted radical prostatectomy in kidney transplant patients: A French multicentre studyMargaux Felber, Sarah J Drouin, Pietro Grande, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 17, 2012
Familial hypomagnesemia with hypercalciuria and nephrocalcinosis: phenotype-genotype correlation and outcome in 32 patients with CLDN16 or CLDN19 mutationsAstrid Godron, Jérôme Harambat, Valérie Boccio, et al.
International Journal of Oncology|July 30, 2009
Massive expansion of regulatory T-cells following interleukin 2 treatment during a phase I-II dendritic cell-based immunotherapy of metastatic renal cancerFrançois M Lemoine, Mustapha Cherai, Camille Giverne, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 14, 2020
Microvasculature partial endothelial mesenchymal transition in early posttransplant biopsy with acute tubular necrosis identifies poor recovery renal allograftsYi-Chun Xu-Dubois, Pedram Ahmadpoor, Isabelle Brocheriou, et al.
BMC Genomics|November 18, 2010
Insights into metazoan evolution from Alvinella pompejana cDNAsNicolas Gagnière, Didier Jollivet, Isabelle Boutet, et al.
Transplantation|November 12, 2015
One-year Results of the Effects of Rituximab on Acute Antibody-Mediated Rejection in Renal Transplantation: RITUX ERAH, a Multicenter Double-blind Randomized Placebo-controlled TrialBénédicte Sautenet, Gilles Blancho, Mathias Büchler, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 17, 2022
One-month humoral response following two or three doses of messenger RNA coronavirus disease 2019 vaccines as primary vaccination in specific populations in France: first results from the Agence Nationale Recherche contre le Sida (ANRS)0001S COV-POPART cohortPaul Loubet, Linda Wittkop, Laetitia Ninove, et al.
BMC Infectious Diseases|September 28, 2024
Association between humoral serological markers levels and risk of SARS-CoV-2 infection after the primary COVID-19 vaccine course among ANRS0001S COV-POPART cohort participantsMathieu Chalouni, Paul Loubet, Edouard Lhomme, et al.
Virology Journal|April 25, 2025
SARS-CoV-2 lineage-dependent temporal phylogenetic distribution and viral load in immunocompromised and immunocompetent individualsKaren Zafilaza, Antoine Fauchois, Valentin Leducq, et al.
Pageof 11